BETHEL, Conn., Dec. 15 /PRNewswire-FirstCall/ -- Aduromed Industries, Inc. (OTC Bulletin Board: ADRM), a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste, today announced that Richard W. Wolfe has been elected to the Company's board of directors. Mr. Wolfe has 30 years of executive leadership, extensive public policy and political advocacy experience, and is recognized for designing and implementing innovative programs in the health care field. He currently owns health care companies throughout the southeastern US, including Subacute Services, Inc. and Sunrise Health and Rehabilitation Center, which provide subacute, long-term care, home health care and related services. Previously, he was CEO, Vice Chairman of the Board, and Chairman of the Executive Committee of a NYSE-listed hospital company providing acute care, behavioral, rehabilitation and long term acute care services. Prior to that, he was a partner in the Dillard & Wolfe, PC law firm where he was Counsel to the Majority Leader of the Georgia Senate. Mr. Wolfe has his J.D. from the Woodrow Wilson College of Law in Atlanta and has a B.A. from Western Kentucky University where he serves as a member of the Advisory Board and as a visiting lecturer in the Gordon Ford School of Business.

Mr. Joseph Esposito, Chairman of the Board of Directors, commented, "Richard Wolfe is an outstanding addition to the Aduromed board. His proven leadership, deep understanding of the healthcare public policy and advocacy arena and his ability to develop innovative programs has earned him broad recognition. We value this forward thinking approach and know that his expertise and reputation will augment our board as we develop and execute our strategic plan."

Mr. Wolfe added, "It is clear to me that Aduromed has innovative and industry-leading technology and, I am eager to assist them as they implement their growth initiatives. I believe their integrated technology addresses the issues of most concern to healthcare organizations, which are seeking easy to implement solutions for handling challenges associated with regulated medical waste that are cost effective, mitigate risk, and enhance institutions' Green profiles and standing in host communities. I am honored to join the Aduromed board and look forward to helping them deliver value to their shareholders."

About Aduromed Industries, Inc.

Aduromed Industries, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. Aduromed's flagship MedClean(R) Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. Aduromed was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on Aduromed can be found at http://www.aduromed.com and in filings with the Securities and Exchange Commission found at http://www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2007, filed with the SEC on March 31, 2008, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.



     Contacts:
     Aduromed Industries, Inc.    Investor Contact:
     Kevin Dunphy                 Cameron Donahue
     Chief Financial Officer      Hayden IR
     (203) 798-1080               (651) 653-1854
     kdunphy@aduromed.com         cameron@haydenir.com

SOURCE Aduromed Industries, Inc.